Cargando…
Correlation of DRD2 mRNA expression levels with deficit syndrome severity in chronic schizophrenia patients receiving clozapine treatment
Schizophrenia is a complex, severe, chronic psychiatric disorder, and the associated deficit syndrome is widely regarded as an important clinical aspect of schizophrenia. This study analyzed the relationship of deficit syndrome severity with the mRNA levels of members of signaling pathways that asso...
Autores principales: | Liu, Liang, Luo, Yin, Zhang, Guofu, Jin, Chunhui, Zhou, Zhenhe, Cheng, Zaohuo, Yuan, Guozhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689702/ https://www.ncbi.nlm.nih.gov/pubmed/29156812 http://dx.doi.org/10.18632/oncotarget.21230 |
Ejemplares similares
-
Identification of the mRNA Expression Status of the Dopamine D2 Receptor and Dopamine Transporter in Peripheral Blood Lymphocytes of Schizophrenia Patients
por: Liu, Liang, et al.
Publicado: (2013) -
Altered expression of mRNA profiles in blood of early-onset schizophrenia
por: Xu, Yong, et al.
Publicado: (2016) -
Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia
por: Michalczyk, Anna, et al.
Publicado: (2020) -
Increased Variability of Genomic Transcription in Schizophrenia
por: Zhang, Fuquan, et al.
Publicado: (2015) -
M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
por: Lee, Jimmy, et al.
Publicado: (2020)